NYSE : ABBV

AbbVie Inc. — Financial statements

Healthcare · Drug Manufacturers - General · United States

Last price 294.89 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 521.11B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

AbbVie Inc. (ABBV) reported revenue of 66.01B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue66.01B61.16B56.33B54.32B58.05B56.20B
Cost of Revenue17.35B17.36B16.69B16.83B16.53B17.31B
Gross Profit48.66B43.80B39.65B37.49B41.53B38.88B
Selling, General & Admin14.74B13.64B14.10B12.42B14.58B11.87B
Research & Development9.87B9.07B8.13B7.04B6.49B6.82B
Other Operating Expenses-18.00M-24.00M-7.00M-179.00M228.00M432.00M
Operating Expenses24.59B22.69B22.22B19.28B21.30B19.12B
Operating Income24.07B21.11B17.42B18.21B20.23B19.76B
Interest Expense-2.93B-2.89B-2.81B-2.22B-2.23B-2.42B
Interest & Investment Income266.00M266.00M648.00M540.00M186.00M39.00M
Currency Exchange Gain (Loss)-58.00M-58.00M-21.00M-146.00M-148.00M-51.00M
Other Non Operating Income (Expenses)159.00M403.00M271.00M190.00M142.00M55.00M
EBT Excluding Unusual Items21.51B18.83B15.51B16.57B18.18B17.38B
Merger & Restructuring Charges-253.00M-95.00M-792.00M-288.00M-539.00M-587.00M
Gain (Loss) on Sale of Assets172.00M
Asset Writedown-847.00M-4.48B-4.13B-876.00M
Other Unusual Items-5.92B-6.28B-3.77B-5.13B-2.76B-2.68B
Pretax Income12.81B6.60B3.72B6.25B13.48B12.99B
Income Tax Expense2.47B2.36B-570.00M1.38B1.63B1.44B
Earnings From Continuing Operations10.35B4.23B4.29B4.87B11.85B11.55B
Minority Interest in Earnings-6.00M-7.00M-8.00M-10.00M-9.00M-7.00M
Net Income10.34B4.23B4.28B4.86B11.84B11.54B
Preferred Dividends & Other Adjustments40.00M40.00M40.00M43.00M54.00M74.00M
Net Income to Common10.30B4.19B4.24B4.82B11.78B11.47B
Shares Outstanding (Basic)1.77B1.77B1.77B1.77B1.77B1.77B
Shares Outstanding (Diluted)1.77B1.77B1.77B1.77B1.78B1.78B
EPS (Basic)5.822.372.402.736.656.48
EPS (Diluted)5.812.362.392.726.636.45
Free Cash Flow17.82B17.83B22.06B24.25B21.99B
Free Cash Flow Per Share10.0510.0612.4413.6412.38
Dividend Per Share6.926.656.295.995.715.31
Gross Margin73.72%71.62%70.38%69.02%71.53%69.19%
Operating Margin36.46%34.52%30.93%33.53%34.84%35.16%
Profit Margin15.61%6.84%7.52%8.87%20.29%20.41%
Free Cash Flow Margin29.13%31.65%40.62%41.77%39.13%
EBITDA31.71B29.25B25.81B26.91B28.70B28.28B
EBITDA Margin48.03%47.83%45.81%49.55%49.43%50.32%
D&A For EBITDA7.64B8.14B8.39B8.70B8.47B8.52B
EBIT24.07B21.11B17.42B18.21B20.23B19.76B
EBIT Margin36.46%34.52%30.93%33.53%34.84%35.16%
Effective Tax Rate19.24%35.83%22.03%12.11%11.09%
Advertising Expenses2.10B2.10B2.20B2.00B2.10B

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents5.23B5.52B12.81B9.20B9.75B
Short-Term Investments28.00M31.00M2.00M28.00M84.00M
Cash & Short-Term Investments6.57B5.26B5.55B12.82B9.23B9.83B
Accounts Receivable12.59B10.92B11.15B11.25B9.98B
Receivables12.59B10.92B11.15B11.25B9.98B
Inventory4.95B4.18B4.10B3.58B3.13B
Prepaid Expenses6.21B4.76B4.87B4.31B4.77B
Other Current Assets60.00M165.00M66.00M88.00M226.00M
Total Current Assets29.06B25.58B33.00B28.46B27.93B
Property, Plant & Equipment6.37B5.86B5.73B5.67B5.87B
Long-Term Investments298.00M279.00M304.00M241.00M303.00M
Goodwill35.64B34.96B32.29B32.16B32.38B
Other Intangible Assets52.64B60.07B55.61B67.44B75.95B
Other Long-Term Assets9.95B8.42B7.77B4.83B4.10B
Total Assets133.96B135.16B134.71B138.81B146.53B
Accounts Payable3.59B2.94B3.69B2.93B2.88B
Accrued Expenses17.24B16.82B15.79B12.50B10.70B
Short-Term Debt2.50B1.00M14.00M
Current Portion of Long-Term Debt6.06B6.79B7.18B4.13B12.48B
Current Portion of Leases213.00M195.00M181.00M183.00M187.00M
Other Current Liabilities13.68B12.01B11.01B9.79B8.93B
Total Current Liabilities43.29B38.75B37.84B29.54B35.19B
Long-Term Debt58.92B60.55B52.46B59.49B64.18B
Long-Term Leases711.00M720.00M762.00M771.00M738.00M
Pension & Post-Retirement Benefits1.41B1.23B1.54B1.64B3.15B
Long-Term Deferred Tax Liabilities2.39B2.58B1.95B2.19B3.01B
Other Long-Term Liabilities30.47B27.97B29.76B27.89B24.82B
Total Liabilities137.19B131.80B124.31B121.52B131.09B
Common Stock18.00M18.00M18.00M18.00M18.00M
Additional Paid-In Capital22.50B21.33B20.18B19.25B18.30B
Retained Earnings-15.49B-7.90B-1.00B4.78B3.13B
Treasury Stock-9.15B-8.20B-6.53B-4.59B-3.14B
Comprehensive Income & Other-1.14B-1.93B-2.31B-2.20B-2.90B
Total Common Equity-5.93B-3.27B3.33B10.36B17.25B15.41B
Minority Interest42.00M39.00M37.00M33.00M28.00M
Shareholders' Equity-5.89B-3.23B3.36B10.40B17.29B15.44B
Total Liabilities & Equity133.96B135.16B134.71B138.81B146.53B
Total Debt70.89B68.40B68.25B60.58B64.58B77.60B
Net Cash (Debt)-64.32B-63.14B-62.70B-47.76B-55.35B-67.77B
Net Cash Per Share-36.28-35.61-35.36-26.94-31.13-38.14
Filing Date Shares Outstanding1.77B1.77B1.77B1.77B1.77B1.77B
Total Common Shares Outstanding1.77B1.77B1.77B1.77B1.77B1.77B
Working Capital-14.23B-13.17B-4.84B-1.07B-7.27B
Book Value Per Share-3.36-1.851.885.879.758.71
Tangible Book Value-90.59B-91.55B-91.70B-77.54B-82.34B-92.92B
Tangible Book Value Per Share-51.27-51.79-51.95-43.91-46.54-52.55
Land287.00M284.00M286.00M286.00M287.00M
Buildings3.06B2.90B2.83B2.74B2.79B
Machinery8.79B8.00B7.45B7.11B6.85B
Construction In Progress1.40B1.09B1.07B856.00M799.00M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income4.23B4.28B4.86B11.84B11.54B
Depreciation & Amortization8.14B8.39B8.70B8.47B8.52B
Loss (Gain) From Sale of Assets-172.00M-68.00M
Asset Writedown & Restructuring Costs5.86B7.23B5.01B1.47B1.17B
Stock-Based Compensation955.00M911.00M747.00M671.00M692.00M
Other Operating Activities2.21B780.00M711.00M2.77B2.15B
Change in Accounts Receivable-1.49B207.00M66.00M-1.46B-1.32B
Change in Inventory-234.00M-319.00M-417.00M-686.00M-142.00M
Change in Accounts Payable951.00M177.00M3.84B1.77B1.72B
Change in Other Net Operating Assets-827.00M361.00M-188.00M-264.00M-197.00M
Operating Cash Flow19.03B18.81B22.84B24.94B22.78B
Capital Expenditures-1.21B-974.00M-777.00M-695.00M-787.00M
Cash Acquisitions-5.44B-20.52B-1.22B-794.00M-1.90B
Investment in Securities41.00M482.00M-22.00M92.00M-21.00M
Other Investing Activities-29.00M189.00M13.00M774.00M366.00M
Investing Cash Flow-6.64B-20.82B-2.01B-623.00M-2.34B
Short-Term Debt Issued5.30B5.01B
Long-Term Debt Issued3.99B16.96B2.00B1.00B
Total Debt Issued9.29B21.97B2.00B1.00B
Short-Term Debt Repaid-2.80B-5.01B
Long-Term Debt Repaid-6.80B-9.61B-4.15B-14.43B-9.41B
Total Debt Repaid-9.60B-14.62B-4.15B-14.43B-9.41B
Net Debt Issued (Repaid)-304.00M7.35B-4.15B-12.43B-8.41B
Issuance of Common Stock172.00M214.00M180.00M262.00M244.00M
Repurchase of Common Stock-980.00M-1.71B-1.97B-1.49B-934.00M
Common Dividends Paid-11.66B-11.03B-10.54B-10.04B-9.26B
Other Financing Activities45.00M-42.00M-742.00M-1.10B-674.00M
Financing Cash Flow-12.72B-5.21B-17.22B-24.80B-19.04B
Foreign Exchange Rate Adjustments42.00M-65.00M5.00M-62.00M-97.00M
Net Cash Flow-295.00M-7.29B3.61B-545.00M1.30B
Free Cash Flow17.82B17.83B22.06B24.25B21.99B
Free Cash Flow Margin29.13%31.65%40.62%41.77%39.13%
Free Cash Flow Per Share10.0510.0612.4413.6412.38
Levered Free Cash Flow18.34B19.41B22.97B21.26B19.39B
Unlevered Free Cash Flow20.15B21.16B24.36B22.65B20.91B
Cash Interest Paid3.00B2.81B2.47B2.55B2.71B
Cash Income Tax Paid3.63B4.10B4.70B2.99B3.65B
Change in Working Capital-2.36B-2.78B2.81B-94.00M-1.23B

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization509.46B403.83B314.02B273.61B285.71B239.37B
Enterprise Value573.78B467.05B378.10B321.53B343.86B307.89B
Last Close Price294.89221.85166.71140.26140.59113.37
PE Ratio49.6496.4774.1056.7724.2520.87
Forward PE18.3316.5714.8113.9612.7210.04
PS Ratio7.896.605.575.044.924.26
PB Ratio-125.1093.3526.3216.5315.51
P/FCF Ratio28.6222.6717.6112.4011.7810.88
P/OCF Ratio26.7121.2216.7011.9811.4510.51
PEG Ratio1.381.091.6858.4393.442.03
EV/Sales Ratio8.877.646.715.925.925.48
EV/EBITDA Ratio18.4615.9614.6511.9511.9810.89
EV/EBIT Ratio24.3222.1221.7017.6517.0015.58
EV/FCF Ratio32.1526.2121.2014.5714.1814.00
Debt / Equity Ratio-12.04-21.1920.295.833.745.03
Debt / EBITDA Ratio2.212.312.612.232.222.71
Debt / FCF Ratio3.843.832.752.663.53
Net Debt / Equity Ratio-10.92-19.5618.644.593.204.39
Net Debt / EBITDA Ratio2.032.162.431.771.932.40
Net Debt / FCF Ratio3.543.522.172.283.08
Asset Turnover0.460.420.400.410.38
Inventory Turnover3.804.034.384.935.38
Quick Ratio0.410.420.630.690.56
Current Ratio0.670.660.870.960.79
Return on Equity (ROE)6,225.00%62.29%35.20%72.40%80.95%
Return on Assets (ROA)9.81%8.07%8.32%8.86%8.31%
Return on Invested Capital (ROIC)17.29%28.05%21.71%22.82%20.09%
Return on Capital Employed (ROCE)23.30%18.10%18.80%18.50%17.70%
Earnings Yield2.01%1.05%1.36%1.78%4.14%4.82%
FCF Yield3.49%4.41%5.68%8.06%8.49%9.19%
Dividend Yield2.40%2.91%3.54%3.87%3.54%3.92%
Payout Ratio119.14%275.84%257.71%216.72%84.85%80.24%
Buyback Yield / Dilution-0.06%0.28%-0.06%-6.22%
Total Shareholder Return2.35%2.91%3.48%4.15%3.48%-2.29%